Actinogen Medical Limited
ATGGF
$0.025
$0.0014.17%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | 2.12% | -- | |||
| Total Revenue | 2.12% | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 2.12% | -- | |||
| SG&A Expenses | 2.12% | 22.47% | |||
| Depreciation & Amortization | 2.18% | 4.39% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.12% | 43.71% | |||
| Operating Income | -2.12% | 19.49% | |||
| Income Before Tax | -2.12% | 22.66% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2.12% | 22.66% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.12% | 22.66% | |||
| EBIT | -2.12% | 19.49% | |||
| EBITDA | -2.12% | 20.00% | |||
| EPS Basic | 0.00% | 22.22% | |||
| Normalized Basic EPS | 0.00% | 33.33% | |||
| EPS Diluted | 0.00% | 22.22% | |||
| Normalized Diluted EPS | 0.00% | 33.33% | |||
| Average Basic Shares Outstanding | 0.00% | 4.26% | |||
| Average Diluted Shares Outstanding | 0.00% | 4.26% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||